arginine vasopressin has been researched along with Brain Damage, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decaux, G; Penninckx, R; Perier, O; Soupart, A; Stenuit, A | 1 |
| Autti-Rämö, I; Granström, ML; Korkman, M; Raivio, KO; Ruth, V | 1 |
| Akerlund, M; Forsling, ML; Lindvall, B; Olsson, JE | 1 |
3 other study(ies) available for arginine vasopressin and Brain Damage, Chronic
| Article | Year |
|---|---|
Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms.
Topics: Animals; Arginine Vasopressin; Brain Damage, Chronic; Brain Diseases, Metabolic; Demyelinating Diseases; Hyponatremia; Hypotonic Solutions; Male; Motor Activity; Osmotic Pressure; Rats; Rats, Wistar; Saline Solution, Hypertonic; Sodium; Water | 1996 |
Prediction of perinatal brain damage by cord plasma vasopressin, erythropoietin, and hypoxanthine values.
Topics: Arginine Vasopressin; Asphyxia Neonatorum; Brain Damage, Chronic; Cerebral Palsy; Erythropoietin; Female; Fetal Blood; Humans; Hypoxanthine; Hypoxanthines; Infant, Newborn; Male; Pre-Eclampsia; Pregnancy; Prognosis | 1988 |
Cerebrospinal fluid arginine vasopressin in Parkinson's disease, dementia, and other degenerative disorders.
Topics: Arginine Vasopressin; Blood-Brain Barrier; Brain Damage, Chronic; Cerebrovascular Disorders; Dementia; Female; Humans; Male; Middle Aged; Parkinson Disease | 1987 |